The roles of myeloid-derived suppressor cells in transplantation

References

• Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 2008;8(8):618-31
   PubMed Web of Science ®Google Scholar
• Almand B, Clark JI, Nikitina E, et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 2001;166(1):678-89
   PubMed Web of Science ®Google Scholar
• Mandruzzato S, Solito S, Falisi E, et al. IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. J Immunol 2009;182(10):6562-8
   PubMed Web of Science ®Google Scholar
• Movahedi K, Guilliams M, Van den Bossche J, et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008;111(8):4233-44
   PubMed Web of Science ®Google Scholar
• Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008;181(8):5791-802
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9(3):162-74
   PubMed Web of Science ®Google Scholar
• Nagaraj S, Gupta K, Pisarev V, et al. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med 2007;13(7):828-35
   PubMed Web of Science ®Google Scholar
• De Wilde V, Van Rompaey N, Hill M, et al. Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am J Transplant 2009;9(9):2034-47
   PubMed Web of Science ®Google Scholar
• Li H, Han Y, Guo Q, et al. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. J Immunol 2009;182(1):240-9
   PubMed Web of Science ®Google Scholar
• Jia W, Jackson-Cook C, Graf MR. Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model. J Neuroimmunol 2010;223(1-2):20-30
   PubMed Web of Science ®Google Scholar
• Obermajer N, Muthuswamy R, Lesnock J, et al. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood 2011;118(20):5498-505
   PubMed Web of Science ®Google Scholar
• Baban B, Chandler PR, Johnson BA 3rd, et al. Physiologic control of IDO competence in splenic dendritic cells. J Immunol 2011;187(5):2329-35
   PubMed Web of Science ®Google Scholar
• Lindau D, Gielen P, Kroesen M, et al. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology 2013;138(2):105-15
   PubMed Web of Science ®Google Scholar
• Chou HS, Hsieh CC, Charles R, et al. Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells. Transplantation 2012;93(3):272-82
   PubMedGoogle Scholar
• Saleem SJ, Conrad DH. Hematopoietic cytokine-induced transcriptional regulation and notch signaling as modulators of MDSC expansion. Int Immunopharmacol 2011;11(7):808-15
   PubMedGoogle Scholar
• Sinha P, Okoro C, Foell D, et al. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 2008;181(7):4666-75
   PubMed Web of Science ®Google Scholar
• Hsieh CC, Chou HS, Yang HR, et al. The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood 2013;121(10):1760-8
   PubMedGoogle Scholar
• Mao Y, Sarhan D, Steven A, et al. Inhibition of tumor-derived prostaglandin-E2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity. Clin Cancer Res 2014. [Epub ahead of print]
   Google Scholar
• Zhou Z, French DL, Ma G, et al. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Cells 2010;28(3):620-32
   PubMedGoogle Scholar
• Highfill SL, Rodriguez PC, Zhou Q, et al. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 2010;116(25):5738-47
   PubMed Web of Science ®Google Scholar
• Holda JH, Maier T, Claman HN. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. I. Impairment of mitogen responses and suppressor phenomena. J Immunol 1985;134(3):1397-402
   PubMedGoogle Scholar
• Holda JH, Maier T, Claman HN. Murine graft-versus-host disease across minor barriers: immunosuppressive aspects of natural suppressor cells. Immunol Rev 1985;88:87-105
   PubMed Web of Science ®Google Scholar
• Oseroff A, Okada S, Strober S. Natural suppressor (NS) cells found in the spleen of neonatal mice and adult mice given total lymphoid irradiation (TLI) express the null surface phenotype. J Immunol 1984;132(1):101-10
   PubMedGoogle Scholar
• Strober S. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. Annu Rev Immunol 1984;2:219-37
   PubMed Web of Science ®Google Scholar
• Hill GR, Crawford JM, Cooke KR, et al. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997;90(8):3204-13
   PubMed Web of Science ®Google Scholar
• Singh VK, Fatanmi OO, Singh PK, Whitnall MH. Role of radiation-induced granulocyte colony-stimulating factor in recovery from whole body gamma-irradiation. Cytokine 2012;58(3):406-14
   PubMedGoogle Scholar
• Luyckx A, Schouppe E, Rutgeerts O, et al. Subset characterization of myeloid-derived suppressor cells arising during induction of BM chimerism in mice. Bone Marrow Transplant 2012;47(7):985-92
   PubMedGoogle Scholar
• Sprangers B, Van Wijmeersch B, Luyckx A, et al. Subclinical GvHD in non-irradiated F1 hybrids: severe lymphoid-tissue GvHD causing prolonged immune dysfunction. Bone Marrow Transplant 2011;46(4):586-96
   PubMedGoogle Scholar
• Mougiakakos D, Jitschin R, von Bahr L, et al. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation. Leukemia 2013;27(2):377-88
   PubMed Web of Science ®Google Scholar
• Mielcarek M, Martin PJ, Torok-Storb B. Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 1997;89(5):1629-34
   PubMed Web of Science ®Google Scholar
• MacDonald KP, Rowe V, Clouston AD, et al. Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells. J Immunol 2005;174(4):1841-50
   PubMed Web of Science ®Google Scholar
• Joo YD, Lee SM, Lee SW, et al. Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism. Immunology 2009;128(1 Suppl):e632-40
   Google Scholar
• Ghansah T, Paraiso KH, Highfill S, et al. Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses. J Immunol 2004;173(12):7324-30
   PubMedGoogle Scholar
• Wang D, Yu Y, Haarberg K, et al. Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice. Biol Blood Marrow Transplant 2013;19(5):692-702
   PubMedGoogle Scholar
• Dugast AS, Haudebourg T, Coulon F, et al. Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol 2008;180(12):7898-906
   PubMed Web of Science ®Google Scholar
• Luan Y, Mosheir E, Menon MC, et al. Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion. Am J Transplant 2013;13(12):3123-31
   PubMed Web of Science ®Google Scholar
• Meng F, Chen S, Guo X, et al. Clinical significance of myeloid-derived suppressor cells in human renal transplantation with acute T cell-mediated rejection. Inflammation 2014. [ Epub ahead of print]
   Google Scholar
• Hock BD, Mackenzie KA, Cross NB, et al. Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells. Nephrol Dial Transplant 2012;27(1):402-10
   PubMedGoogle Scholar
• Pillay J, Kamp VM, van Hoffen E, et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 2012;122(1):327-36
   PubMed Web of Science ®Google Scholar
• Garcia MR, Ledgerwood L, Yang Y, et al. Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Invest 2010;120(7):2486-96
   PubMedGoogle Scholar
• Brunner SM, Schiechl G, Falk W, et al. Interleukin-33 prolongs allograft survival during chronic cardiac rejection. Transpl Int 2011;24(10):1027-39
   PubMedGoogle Scholar
• Ge F, Yuan S, Su L, et al. Alteration of innate immunity by donor IL-6 deficiency in a presensitized heart transplant model. PLoS One 2013;8(10):e77559
   Google Scholar
• Bryant J, Lerret NM, Wang JJ, et al. Preemptive donor apoptotic cell infusions induce IFN-gamma-producing myeloid-derived suppressor cells for cardiac allograft protection. J Immunol 2014;192(12):6092-101
   PubMedGoogle Scholar
• Zhang W, Liang S, Wu J, Horuzsko A. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts. Transplantation 2008;86(8):1125-34
   PubMedGoogle Scholar
• Pan L, Delmonte J Jr, Jalonen CK, Ferrara JL. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995;86(12):4422-9
   PubMedGoogle Scholar
• Tang Q, Adams JY, Penaranda C, et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 2008;28(5):687-97
   PubMed Web of Science ®Google Scholar
• Adeegbe D, Serafini P, Bronte V, et al. In vivo induction of myeloid suppressor cells and CD4(+)Foxp3(+) T regulatory cells prolongs skin allograft survival in mice. Cell Transplant 2011;20(6):941-54
   PubMedGoogle Scholar
• Gong W, Ge F, Liu D, et al. Role of myeloid-derived suppressor cells in mouse pre-sensitized cardiac transplant model. Clin Immunol 2014;153(1):8-16
   PubMedGoogle Scholar
• Wu T, Sun C, Chen Z, et al. Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway. J Immunol 2012;189(10):4989-5000
   PubMedGoogle Scholar
• Yang HR, Chou HS, Gu X, et al. Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon-gamma signaling. Hepatology 2009;50(6):1981-91
   PubMed Web of Science ®Google Scholar
• Arakawa Y, Qin J, Chou HS, et al. Co transplantation with myeloid-derived suppressor cells protects cell transplants: a crucial role of inducible nitric oxide syntheses. Transplantation 2014;97(7):740-7
   PubMedGoogle Scholar
• Maeda A, Kawamura T, Ueno T, et al. Monocytic suppressor cells derived from human peripheral blood suppress xenogenic immune reactions. Xenotransplantation 2013. [ Epub ahead of print]
   PubMedGoogle Scholar
• Maenhout SK, Van Lint S, Emeagi PU, et al. Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts. Int J Cancer 2014;134(5):1077-90
   PubMedGoogle Scholar
• Le Blanc K, Jitschin R, Mougiakakos D. Myeloid-derived suppressor cells in allogeneic hematopoietic stem cell transplantation: a double-edged sword? Oncoimmunology 2013;2(7):e25009
   Google Scholar
• Laskowski I, Pratschke J, Wilhelm MJ, et al. Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant 2000;5(4):29-35
   PubMedGoogle Scholar
• Condamine T, Gabrilovich DI. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol 2011;32(1):19-25
   PubMed Web of Science ®Google Scholar
• Oka T, Hikoso S, Yamaguchi O, et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 2012;485(7397):251-5
   PubMed Web of Science ®Google Scholar
• Tu S, Bhagat G, Cui G, et al. Over expression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 2008;14(5):408-19
   PubMed Web of Science ®Google Scholar
• Yu JR, Yan S, Liu XS, et al. Attenuation of graft ischemia-reperfusion injury by urinary trypsin inhibitor in mouse intestinal transplantation. World J Gastroenterol 2005;11(11):1605-9
   PubMedGoogle Scholar
• Cripps JG, Wang J, Maria A, et al. Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver. Hepatology 2010;52(4):1350-9
   PubMed Web of Science ®Google Scholar
• Konieczny BT, Dai Z, Elwood ET, et al. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998;160(5):2059-64
   PubMedGoogle Scholar
• Gallina G, Dolcetti L, Serafini P, et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 2006;116(10):2777-90
   PubMed Web of Science ®Google Scholar
• Jurgens B, Hainz U, Fuchs D, et al. Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. Blood 2009;114(15):3235-43
   PubMed Web of Science ®Google Scholar
• Ge W, Jiang J, Arp J, et al. Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation 2010;90(12):1312-20
   PubMed Web of Science ®Google Scholar
• Li XL, Menoret S, Bezie S, et al. Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance. J Immunol 2010;185(2):823-33
   PubMedGoogle Scholar
• Guillonneau C, Hill M, Hubert FX, et al. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase. J Clin Invest 2007;117(4):1096-106
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012;12(4):253-68
   PubMed Web of Science ®Google Scholar
• Guillot C, Menoret S, Guillonneau C, et al. Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig. Blood 2003;101(8):3325-33
   PubMedGoogle Scholar
• Koorella C, Nair JR, Murray ME, et al. Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by notch1 in IL-6 and indoleamine 2,3 dioxygenase production by dendritic cells. J Biol Chem 2014;289(11):7747-62
   PubMedGoogle Scholar
• Yang R, Cai Z, Zhang Y, et al. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells. Cancer Res 2006;66(13):6807-15
   PubMed Web of Science ®Google Scholar
• Liu Y, Yu Y, Yang S, et al. Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells. Cancer Immunol Immunother 2009;58(5):687-97
   PubMed Web of Science ®Google Scholar
• Brito C, Naviliat M, Tiscornia AC, et al. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J Immunol 1999;162(6):3356-66
   PubMedGoogle Scholar
• DeNardo DG, Barreto JB, Andreu P, et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009;16(2):91-102
   PubMed Web of Science ®Google Scholar
• Munera V, Popovic PJ, Bryk J, et al. Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin. Ann Surg 2010;251(1):120-6
   PubMed Web of Science ®Google Scholar
• Abadja F, Sarraj B, Ansari MJ. Significance of T helper 17 immunity in transplantation. Curr Opin Organ Transplant 2012;17(1):8-14
   PubMedGoogle Scholar
• Yi H, Guo C, Yu X, et al. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. J Immunol 2012;189(9):4295-304
   PubMed Web of Science ®Google Scholar
• Jiao Z, Hua S, Wang W, et al. Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis. Scand J Rheumatol 2013;42(2):85-90
   PubMed Web of Science ®Google Scholar
• Novitskiy SV, Pickup MW, Gorska AE, et al. TGF-beta receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms. Cancer Discov 2011;1(5):430-41
   PubMedGoogle Scholar
• He D, Li H, Yusuf N, et al. IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells. J Immunol 2010;184(5):2281-8
   PubMed Web of Science ®Google Scholar
• Fujimura T, Ring S, Umansky V, et al. Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas. J Invest Dermatol 2012;132(4):1239-46
   PubMed Web of Science ®Google Scholar
• Maes W, Verschuere T, Van Hoylandt A, et al. Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain. Clin Dev Immunol 2013;2013:952469
   PubMedGoogle Scholar
• Chen CH, Kuo LM, Chang Y, et al. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 2006;44(5):1171-81
   PubMedGoogle Scholar
• Chou HS, Hsieh CC, Yang HR, et al. Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology 2011;53(3):1007-19
   PubMedGoogle Scholar
• Ding Y, Bushell A, Wood KJ. Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation. Transplantation 2010;89(3):270-3
   PubMedGoogle Scholar
• Yen BL, Yen ML, Hsu PJ, et al. Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor/c-Met and STAT3. Stem Cell Reports 2013;1(2):139-51
   PubMed Web of Science ®Google Scholar
• Chen HW, Chen HY, Wang LT, et al. Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines. J Immunol 2013;190(10):5065-77
   PubMedGoogle Scholar
• Varga G, Ehrchen J, Tsianakas A, et al. Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells. J Leukoc Biol 2008;84(3):644-50
   PubMed Web of Science ®Google Scholar
• Ehrchen J, Steinmuller L, Barczyk K, et al. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 2007;109(3):1265-74
   PubMed Web of Science ®Google Scholar
• Zhang K, Bai X, Li R, et al. Endogenous glucocorticoids promote the expansion of myeloid-derived suppressor cells in a murine model of trauma. Int J Mol Med 2012;30(2):277-82
   PubMedGoogle Scholar
• Liao J, Wang X, Bi Y, et al. Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide. J Leukoc Biol 2014. [ Epub ahead of print]
   Google Scholar
• Sevko A, Sade-Feldman M, Kanterman J, et al. Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma. J Invest Dermatol 2013;133(6):1610-19
   PubMed Web of Science ®Google Scholar
• Guo Q, Lv Z, Fu Q, et al. IFN-gamma producing T cells contribute to the increase of myeloid derived suppressor cells in tumor-bearing mice after cyclophosphamide treatment. Int Immunopharmacol 2012;12(2):425-32
   PubMedGoogle Scholar
• Chen X, Yang Y, Zhou Q, et al. Effective chemoimmunotherapy with anti-TGFbeta antibody and cyclophosphamide in a mouse model of breast cancer. PLoS One 2014;9(1):e85398
   Web of Science ®Google Scholar
• Kim YS, Kim YJ, Lee JM, et al. Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs. J Immunol 2012;188(9):4226-34
   PubMedGoogle Scholar
• Wall M, Poortinga G, Hannan KM, et al. Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation. Blood 2008;112(6):2305-17
   PubMedGoogle Scholar
• Zhang Y, Bi Y, Yang H, et al. mTOR limits the recruitment of CD11b+Gr1+Ly6Chigh myeloid-derived suppressor cells in protecting against murine immunological hepatic injury. J Leukoc Biol 2014;95(6):961-70
   PubMedGoogle Scholar
• Trajkovic V. Modulation of inducible nitric oxide synthase activation by immunosuppressive drugs. Curr Drug Metab 2001;2(3):315-29
   PubMedGoogle Scholar
• Niedermeier M, Reich B, Rodriguez Gomez M, et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci USA 2009;106(42):17892-7
   PubMed Web of Science ®Google Scholar
• Yan S, Rodriguez-Barbosa JI, Pabst O, et al. Control of intestinal allograft rejection by FTY720 and costimulation blockade. Transplant Proc 2005;37(1):114-15
   PubMedGoogle Scholar
• Awojoodu AO, Ogle ME, Sefcik LS, et al. Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesis. Proc Natl Acad Sci USA 2013;110(34):13785-90
   PubMed Web of Science ®Google Scholar
• Rygiel TP, Luijk B, Meyaard L. Use of an anti-CD200 antibody for prolonging the survival of allografts: a patent evaluation of WO2012106634A1. Expert Opin Ther Pat 2013;23(3):389-92
   PubMed Web of Science ®Google Scholar
• Hu C, Du W, Zhang X, et al. The role of Gr1+ cells after anti-CD20 treatment in type 1 diabetes in nonobese diabetic mice. J Immunol 2012;188(1):294-301
   PubMed Web of Science ®Google Scholar
• Escors D, Liechtenstein T, Perez-Janices N, et al. Assessing T-cell responses in anticancer immunotherapy: dendritic cells or myeloid-derived suppressor cells? Oncoimmunology 2013;2(10):e26148
   Google Scholar